Difference between revisions of "Aspirin and dipyridamole (Aggrenox)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m |
||
| Line 12: | Line 12: | ||
[[Category:FDA approved in 1999]] | [[Category:FDA approved in 1999]] | ||
| − | |||
Revision as of 21:22, 4 January 2021
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 25 mg of aspirin, as an immediate-release sugar-coated tablet.
Also known as
- Brand name: Aggrenox